Reflections on the Future of Cardiovascular Protection in Vascular Surgery
We are grateful for the detailed and insightful comments by Joakim Nordanstig1 addressing our recent publication about the association between antithrombotic and lipid lowering therapy and improved survival after vascular surgery in Norway.2 We completely agree that optimal medical management goes far beyond the prescription of aspirin and statin and agree with all the examples given in the last paragraph regarding antithrombotic treatment, dyslipidaemia management, and antidiabetic therapies.
Source: European Journal of Vascular and Endovascular Surgery - Category: Surgery Authors: Martin Altreuther, Arne Seternes, Turi Saltnes, Nadia Myrb ΓΈ, Kristin Vikan, Linn Hege Nilsen, Tingting Feng Tags: Letter to the Editor Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cholesterol | Heart | Norway Health | Statin Therapy | Surgery